260 related articles for article (PubMed ID: 21533319)
1. Long-term survival after transarterial chemoembolization for hepatocellular carcinoma.
Iozzino M; Spaziani E; Picchio M; Saltarelli A; Di Filippo A; De Angelis F; Narilli F; Stagnitti F; Cianni R
Clin Ter; 2011; 162(2):129-32. PubMed ID: 21533319
[TBL] [Abstract][Full Text] [Related]
2. [A case of arterial chemoembolization for hepatocellular carcinoma with 11 years of survival].
Iozzino M; Spaziani E; Saltarelli A; Notarianni E; Di Filippo A; Picchio M; Ceci F; De Angelis F; Cipriani B; Nardecchia G; Nicodemi S; Stagnitti F; Cianni R
G Chir; 2008 Oct; 29(10):432-6. PubMed ID: 18947469
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
[TBL] [Abstract][Full Text] [Related]
5. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
[TBL] [Abstract][Full Text] [Related]
6. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors.
Mondazzi L; Bottelli R; Brambilla G; Rampoldi A; Rezakovic I; Zavaglia C; Alberti A; Idèo G
Hepatology; 1994 May; 19(5):1115-23. PubMed ID: 7513677
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma].
Alvarez R; Bañares R; Echenagusía A; Carneros JA; Santos L; Simó G; Camúñez F
Gastroenterol Hepatol; 2000 Apr; 23(4):153-8. PubMed ID: 10863854
[TBL] [Abstract][Full Text] [Related]
8. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
9. [A case of advanced hepatocellular carcinoma with tumor thrombus treated by transarterial chemoembolization therapy using cisplatin (CDDP) with DSM and SAP-MS].
Hori S; Sugiura T; Shirai Y; Hiraishi K
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1477-80. PubMed ID: 16227753
[TBL] [Abstract][Full Text] [Related]
10. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
12. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H
J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
[TBL] [Abstract][Full Text] [Related]
13. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST
Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668
[TBL] [Abstract][Full Text] [Related]
15. [A case report of Vp3 hepatocellular carcinoma responding to multidisciplinary treatment].
Miyamoto A; Kanai T; Tada M; Ebisui C; Okazaki M; Murata A; Hirai T; Murai N; Kouro T
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1732-4. PubMed ID: 9382518
[TBL] [Abstract][Full Text] [Related]
16. Preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
Kobayashi T; Teruya M
Ann Surg; 2010 Feb; 251(2):386; author reply 386-7. PubMed ID: 20040849
[No Abstract] [Full Text] [Related]
17. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
18. Clinical study of transarterial chemoembolization combined with 3-dimensional conformal radiotherapy for hepatocellular carcinoma.
Xu LT; Zhou ZH; Lin JH; Chen Z; Wang K; Wang P; Zhu XY; Shen YH; Meng ZQ; Liu LM
Eur J Surg Oncol; 2011 Mar; 37(3):245-51. PubMed ID: 21195578
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
Miura JT; Gamblin TC
Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transarterial chemoembolization and factors affecting patient prognosis.
Kim HC; Chung JW; Choi SH; Yoon JH; Lee HS; Jae HJ; Lee W; Park JH
J Vasc Interv Radiol; 2007 May; 18(5):611-9; quiz 620. PubMed ID: 17494842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]